Dan Liu

Clinical cardiology researcher at Universitätsklinikum Würzburg / Comprehensive Heart Failure Center with a strong track record in echo-based risk stratification and patient-level registry analyses across heart failure, cardiomyopathy, and valvular disease. Specialized in echocardiography (speckle-tracking imaging) and EchoPAC image analysis. Proficient in SPSS and R; have independently led or co-led the statistical analysis for all publications. Skilled in data interpretation and manuscript writing, applying Cox models, Kaplan–Meier, propensity/PSM, and predictive modeling to deliver clinically meaningful insights.

• Liu D, Hu K, Schimpf V, et al. Relative apical sparing predicts outcomes after TAVR. ESC Heart Fail. 2025.
• Liu D, Hu K, Wagner C, et al. Echo-clinical risk score in ischemic HFrEF. Clin Res Cardiol. 2025.
• Liu D, Cui X, Xu Y, et al. Heart-rate change during hospitalization and outcomes in HFpEF. ESC Heart Fail. 2024.
• Sokalski V, Liu D, Hu K, et al. Echo predictors of outcome in severe aortic stenosis. Clin Res Cardiol. 2024.
• Liu D, Hu K, Schregelmann L, et al. Determinants of EF improvement in HFrEF. ESC Heart Fail. 2023.
• Lenders M, Nordbeck P, Kurschat C, et al.; Liu D. Migalastat observational study (FAMOUS). Eur Heart J Cardiovasc Pharmacother. 2022.
• Chen M, Liu D, Weidemann F, et al. Echo risk factors for LV thrombus after anterior MI. ESC Heart Fail. 2021.
• Liu D, Hu K, Lau K, et al. Diastolic dysfunction and outcomes in HFmrEF/HFrEF. ESC Heart Fail. 2021.
• Kaiser R, Liu D, Arias-Loza P, et al. RV pressure overload and LV torsion in precapillary PH. PLoS One. 2020.
• Maniuc O, Salinger T, Anders F, et al.; Liu D. Impella CP in non-ischaemic cardiogenic shock. ESC Heart Fail. 2019.
• Müntze J, Gensler D, Maniuc O, et al.; Liu D. Migalastat: 1-year enzyme/biomarker response. Clin Pharmacol Ther. 2019.
• Salinger T, Hu K, Liu D, et al. Comorbidities and progression of gradients in aortic stenosis. Cardiol Res Pract. 2018.
• Herrmann S, Fries B, Liu D, et al. Myocardial fibrosis predicts 10-year survival after AVR. Circ Cardiovasc Imaging. 2018.
• Hu K, Liu D, Salinger T, et al. Biomarkers in infiltrative cardiomyopathy with preserved EF. J Thorac Dis. 2018.
• Liu D, Hu K, Schmidt M, et al. Stroke/TIA prediction in Fabry disease without AF. Clin Res Cardiol. 2018.
• Oder D, Liu D, Çeyler N, et al. α-Galactosidase A SNP −10C>T: clinical impact. Medicine (Baltimore). 2018.
• Fries B, Liu D, Hu K, et al. Global longitudinal strain predicts outcome in severe AS. Am J Cardiol. 2017.
• Salinger T, Hu K, Liu D, et al. Cardiac amyloidosis mimicking severe AS—diagnostic pitfalls. BMC Cardiovasc Disord. 2017.
• Liu D, Hu K, Herrmann S, et al. Tei index & longitudinal strain predict outcomes in AL amyloidosis. Int J Cardiovasc Imaging. 2017.
• Hu K, Liu D, Störk S, et al. Echo determinants of 1-year mortality with functional TR. J Card Fail. 2017.
• Oder D, Liu D, Hu K, et al. GLA genotype N215S: specific cardiac Fabry variant. Circ Cardiovasc Genet. 2017.
• Weidemann F, Maier SK, Störk S, et al.; Liu D. Implantable loop recorder in advanced Fabry cardiomyopathy. Am J Cardiol. 2016.
• Seydelmann N, Liu D, Krämer J, et al. High-sensitivity troponin for staging Fabry cardiomyopathy. J Am Heart Assoc. 2016.
• Liu D, Hu K, Nordbeck P, et al. Bull’s-eye strain patterns in cardiomyopathy/LVH. Eur J Med Res. 2016.
• Oder D, Çeyler N, Liu D, et al. Organ manifestations & outcomes in Fabry D313Y. BMJ Open. 2016.
• Gaudron PD, Liu D, Scholz F, et al. Septal bulge: early sign in hypertensive heart disease. J Am Soc Hypertens. 2016.
• Krämer J, Bijnens B, Störk S, et al.; Liu D. LV geometry & BP predict progression in Fabry cardiomyopathy. PLoS One. 2015.
• Herrmann S, Liu D, Hu K, et al. Natural history of low- vs high-gradient AS to severe disease. J Am Soc Echocardiogr. 2015.
• Hu K, Liu D, Nordbeck P, et al. Serial GLS monitoring and outcomes in AL amyloidosis. Int J Cardiovasc Imaging. 2015.
• Weidemann F, Liu D, Hu K, et al. Cardiomyopathy in Friedreich’s ataxia—staging biomarker. Int J Cardiol. 2015.
• Liu D, Hu K, Pelzer HT, et al. Journey of a patient with CTEPH. Eur J Med Res. 2015.
• Weidemann F, Scholz F, Liu D, et al. Heart involvement in Friedreich’s ataxia. Herz. 2015. (German)
• Weismann D, Liu D, Bergen T, et al. Hypertension/cardiomyopathy after pheochromocytoma. Clin Endocrinol (Oxf). 2015.
• Weidemann F, Liu D, Hu K, et al. Assessing systolic function in poor echogenicity. Herz. 2015. (German)
• Liu D, Hu K, Störk S, et al. Diastolic strain rate predicts survival in AL amyloidosis (preserved EF). PLoS One. 2014.
• Liu D, Hu K, Niemann M, et al. Differentiating cardiac amyloidosis from other concentric LVH. Circ Cardiovasc Imaging. 2013.
• Herrmann S, Bijnens B, Störk S, et al.; Liu D. Simple imaging markers predict prognosis in inoperable AS. Am J Cardiol. 2013.
• Weidemann F, Störk S, Liu D, et al. Cardiomyopathy of Friedreich ataxia (review). J Neurochem. 2013.
• Liu D, Hu K, Niemann M, et al. Regional LV function and outcome in AL amyloidosis. PLoS One. 2013.
• Krämer J, Niemann M, Liu D, et al. 2D speckle tracking identifies fibrosis in Fabry disease. Eur Heart J. 2013.
• Hu K, Liu D (co-first), Niemann M, et al. LV systolic function in technically difficult studies. J Am Soc Echocardiogr. 2013.
• Hu K, Liu D (co-first), Herrmann S, et al. Clinical implication of MAPSE. Eur Heart J Cardiovasc Imaging. 2013.
• Niemann M, Liu D (co-first), Hu K, et al. Regional deformation: LV non-compaction vs DCM. Eur J Heart Fail. 2012.
• Hu K, Liu D (co-first), Niemann M, et al. Valsalva fails to unmask pseudonormal diastolic function. Circ Cardiovasc Imaging. 2011.
• Liu D, Niemann M, Hu K, et al. Echo of systolic/diastolic function in cardiac amyloidosis. Am J Cardiol. 2011.
• Niemann M, Breunig F, Beer M, et al.; Liu D. Prominent papillary muscles in Fabry disease. Ultrasound Med Biol. 2011.
• Niemann M, Breunig F, Beer M, et al.; Liu D. Tei index in Fabry disease. J Am Soc Echocardiogr. 2011.